Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01744379 · ClinicalTrials.gov registry record · Phase 1
Single and Multiple Dose Study in Japanese
A Phase 1 study, sponsored by Ardea Biosciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT01744379 is a Phase 1 study that has completed, run by Ardea Biosciences. The registered enrollment target is 40 participants.
The verdict
NCT01744379, a Phase 1 study, has completed, sponsored by Ardea Biosciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study will explore the safety, tolerability, and serum uric acid lowering effect of lesinurad in healthy Japanese males to allow comparison with the Western population.
Interventions
- DRUG Placebo
- DRUG Lesinurad
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01744379
The ClinicalTrials.gov registry entry for NCT01744379 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ardea Biosciences, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01744379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01744379 about?
NCT01744379 is a clinical study titled "Single and Multiple Dose Study in Japanese". This study will explore the safety, tolerability, and serum uric acid lowering effect of lesinurad in healthy Japanese males to allow comparison with the Western population.
What is the current status of trial NCT01744379?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2012-12. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01744379?
The interventions under investigation include: Placebo (DRUG), Lesinurad (DRUG).
Who is sponsoring clinical trial NCT01744379?
This trial is sponsored by Ardea Biosciences, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.